These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 5151119)
21. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients]. Khodashova ML; Iuditskiĭ MV; Semenova OV Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896 [TBL] [Abstract][Full Text] [Related]
22. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548 [No Abstract] [Full Text] [Related]
23. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis. Gyselen A; Verbist L; Cosemans J; Lacquet LM; Prignot J; Simon-Pouthier F; Debrabandere R; Devriendt J Acta Tuberc Pneumol Belg; 1969; 60(3):563-76. PubMed ID: 4906105 [No Abstract] [Full Text] [Related]
24. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects. Eule H; Werner E; Winsel K; Iwainsky H Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4470836 [No Abstract] [Full Text] [Related]
25. [Studies of serum rifampicin concentrations]. Takamoto M; Shinoda A; Kondou H; Nagano H; Kutsukake F; Mochizuki K; Taga Y; Yasutake T; Takano T; Hiro Y Kekkaku; 1986 Aug; 61(8):425-33. PubMed ID: 3784240 [No Abstract] [Full Text] [Related]
26. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report. Ige OM; Bakare NA; Onadeko BO Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469 [TBL] [Abstract][Full Text] [Related]
27. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients]. Ganiev KG; Esanbaev DE; Kirina SB Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983 [No Abstract] [Full Text] [Related]
28. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration. Iwainsky H; Winsel K; Werner E; Eule H Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983 [No Abstract] [Full Text] [Related]
29. [Bacteriological evolution established in 406 tuberculosis patients treated with various combinations with or without rifampicin or INH]. Parrot R; Augier J; Auroy C; Baron A; Boscus M; Deshais B; Gillet P; Laparre C; Marchal G; Naghavi H; Plawner S; Schoepff G Rev Tuberc Pneumol (Paris); 1970; 34(5):709-13. PubMed ID: 5496793 [No Abstract] [Full Text] [Related]
30. [New anti-tubercular agents--rifampicin and ethambutol]. El'nik VI Klin Med (Mosk); 1971 May; 49(5):8-11. PubMed ID: 4946528 [No Abstract] [Full Text] [Related]
31. Resistant mycobacterium tuberculosis: report of a family in Connecticut. Gerstenhaber BJ Conn Med; 1980 Jul; 44(7):416-8. PubMed ID: 6772373 [No Abstract] [Full Text] [Related]
32. A case of probable congenital tuberculosis successfully treated with rifampicin and INH. Kotchabhakdi N; Junnanond C J Med Assoc Thai; 1978 Aug; 61(8):481-8. PubMed ID: 690536 [No Abstract] [Full Text] [Related]
33. [Investigation on bacteriological relapses in cases of pulmonary tuberculosis treated with INH and RFP--report of the 27th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)]. Mochizuki K; Shigeto E; Kobayashi Y; Nagasawa S Kekkaku; 1987 May; 62(5):265-80. PubMed ID: 3626256 [No Abstract] [Full Text] [Related]
34. [Comparative bacteriological development in 2 groups of patients with severe pulmonary tuberculosis, 1 treated with a rifampicin-base combination, the other with an INH-base combination]. Augier J; Parrot R; Marchal G; Gillet P Rev Tuberc Pneumol (Paris); 1969; 33(3):414-23. PubMed ID: 5383011 [No Abstract] [Full Text] [Related]
35. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients]. Kislitsyna NA Probl Tuberk; 1985; (4):55-7. PubMed ID: 4001111 [No Abstract] [Full Text] [Related]
36. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic. Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404 [No Abstract] [Full Text] [Related]
37. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)]. Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655 [TBL] [Abstract][Full Text] [Related]
38. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol]. Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206 [No Abstract] [Full Text] [Related]
39. Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses. Kradolfer F; Schnell R Arzneimittelforschung; 1973 Oct; 23(10):1465-6. PubMed ID: 4591315 [No Abstract] [Full Text] [Related]
40. [Histological characteristics of tuberculous cavity treated with rifampicin--a comparative study with cases treated by primary drugs (author's transl)]. Tanaka I; Iwai K Kekkaku; 1981 Jul; 56(7):355-60. PubMed ID: 7328996 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]